TY - JOUR
T1 - Age-related impairment of intestinal inflammation resolution through an eicosanoid-immune-microbiota axis
AU - Goepp, Marie
AU - Milburn, Jemma V.
AU - Zhang, Birong
AU - Dong, Yijia
AU - Tyrrell, Victoria
AU - Zheng, Xiaozhong
AU - Marshall, Jennifer M.
AU - Bolsega, Silvia
AU - Basic, Marijana
AU - Glendinning, Laura
AU - Ho, Gwo Tzer
AU - Satsangi, Jack
AU - Breyer, Richard M.
AU - Narumiya, Shuh
AU - McSorley, Henry J.
AU - Schwarze, Jürgen K.J.
AU - Anderson, Christopher J.
AU - Dockrell, David H.
AU - Rossi, Adriano G.
AU - Bleich, André
AU - Lucas, Christopher D.
AU - O'Donnell, Valerie B.
AU - Mole, Damian
AU - Arends, Mark J.
AU - Zhou, You
AU - Yao, Chengcan
N1 - Publisher Copyright:
© 2025 The Author(s)
PY - 2025/5/14
Y1 - 2025/5/14
N2 - Aging manifests a decline of immune function, induces microbiome dysbiosis, drives organ inflammation, and impedes the resolution of inflammation. However, the mechanisms underlying age-related intestinal inflammation remain poorly described. Here, we find that the resolution of T cell-initiated intestinal inflammation is impaired with aging. This impairment is mediated by disrupting the immune-microbiota interplay, controlled by intestinal eicosanoid metabolism. Pharmacologically inhibiting eicosanoid biosynthesis, blocking the prostaglandin E receptor subtype 4 (EP4), or genetically ablating EP4 diminishes age-related impairment of intestinal inflammation resolution. Mechanistically, mononuclear phagocyte-intrinsic eicosanoid-EP4 signaling impedes the resolution of intestinal inflammation through fostering gut microbial dysbiosis and, more importantly, interrupting segmented filamentous bacterial adhesion to the intestinal epithelium. Colonization with EP4-ablated mouse microbiota or segmented filamentous bacteria improves the resolution of intestinal inflammation. These findings reveal that eicosanoid-dependent immune-microbiota interactions impair inflammation resolution in the aged intestine, highlighting potential intervention strategies for improving age-related gut health.
AB - Aging manifests a decline of immune function, induces microbiome dysbiosis, drives organ inflammation, and impedes the resolution of inflammation. However, the mechanisms underlying age-related intestinal inflammation remain poorly described. Here, we find that the resolution of T cell-initiated intestinal inflammation is impaired with aging. This impairment is mediated by disrupting the immune-microbiota interplay, controlled by intestinal eicosanoid metabolism. Pharmacologically inhibiting eicosanoid biosynthesis, blocking the prostaglandin E receptor subtype 4 (EP4), or genetically ablating EP4 diminishes age-related impairment of intestinal inflammation resolution. Mechanistically, mononuclear phagocyte-intrinsic eicosanoid-EP4 signaling impedes the resolution of intestinal inflammation through fostering gut microbial dysbiosis and, more importantly, interrupting segmented filamentous bacterial adhesion to the intestinal epithelium. Colonization with EP4-ablated mouse microbiota or segmented filamentous bacteria improves the resolution of intestinal inflammation. These findings reveal that eicosanoid-dependent immune-microbiota interactions impair inflammation resolution in the aged intestine, highlighting potential intervention strategies for improving age-related gut health.
KW - aging
KW - eicosanoid
KW - EP4 receptor
KW - gut microbiota
KW - intestinal inflammation
KW - mononuclear phagocyte
KW - pathogenic T cells
KW - prostaglandin E
KW - resolution of inflammation
KW - segmented filamentous bacteria
UR - https://www.scopus.com/pages/publications/105004602335
U2 - 10.1016/j.chom.2025.04.014
DO - 10.1016/j.chom.2025.04.014
M3 - Article
C2 - 40373750
AN - SCOPUS:105004602335
SN - 1931-3128
VL - 33
SP - 671-687.e6
JO - Cell Host and Microbe
JF - Cell Host and Microbe
IS - 5
ER -